Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer.

@article{Pertschuk1993SteroidHR,
  title={Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer.},
  author={LouisP. Pertschuk and JosephG. Feldman and Dong Sun Kim and Kamran Nayeri and Kurt B. Eisenberg and Anne C. Carter and William Thelmo and Z T Rhong and Peter Benn and Ashley Grossman},
  journal={Cancer},
  year={1993},
  volume={71 1},
  pages={
          162-71
        }
}
BACKGROUND It is important to develop parameters that aid in prognosticating which patients with breast cancer are more likely to have a rapid disease course and therefore might benefit from early aggressive therapies. METHODS Specimens from two groups of women, deliberately selected because their clinical courses differed greatly, were studied to detect amplification of the protooncogenes c-myc, int-2, and C-erbB-2/neu by slot-blot assay, the estrogen receptor (ER), and the progesterone… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

c-Myc in breast cancer.

  • Endocrine-related cancer
  • 2000
VIEW 1 EXCERPT
CITES BACKGROUND
HIGHLY INFLUENCED

Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2013
VIEW 1 EXCERPT
CITES RESULTS

Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2004

Similar Papers

Loading similar papers…